InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Nichols David Wayne, Chief Technology Officer. Director active across 1 companies, notably Magenta Therapeutics, Inc.. Aggregated, 4 reports have been recorded. Total volume traded: €65k. The latest transaction was disclosed on 16 September 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€32,5655,694 shares@ €5.7192100.0% of flow
Common Stock
SEC:0000899243-21-036595·
€32,5655,694 shares@ €5.719250.0% of flow
Common Stock
SEC:0000899243-21-036595:0·
020,000 shares0
Common Stock
SEC:0000899243-21-036333·
020,000 shares0
Common Stock
SEC:0000899243-21-036333:0·
4 of 4 declarations
About Nichols David Wayne
David Wayne Nichols is the Chief Technical Officer at Magenta Therapeutics, Inc. He is responsible for technical direction and product innovation. David leverages his expertise to guide technological development and ensure the quality of the solutions offered by the company.
